CVKD vs TTWO · $20.2M cap vs rev $6.66B
Cadrenal Therapeutics, Inc. Common Stock (CVKD) versus Take-Two Interactive Software Inc (TTWO) — a side-by-side from cached financials, not a winner call.
Cadrenal Therapeutics, Inc. Common Stock (CVKD) is a biotechnology company listed on US.
Take-Two Interactive Software Inc (TTWO) is a electronic gaming & multimedia company listed on NASDAQ.
CVKD does not have a complete income-statement cache yet.
Latest reported TTWO revenue for 2026-03-31 was $6.66B. Net income was -$298.2M. Revenue was up 18.2% from 2025-03-31 to 2026-03-31. TTWO currently screens at market cap $42.34B.
CVKD currently screens at market cap $20.2M. TTWO currently screens at market cap $42.34B.
Not investment advice. Open the CVKD and TTWO stock pages for the full models.
Not investment advice.